Emerging antivirals for the treatment of hepatitis B

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 24

Peer-Review Report of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 28, 2014; 20(24): 7707-7717
Published online Jun 28, 2014. doi: 10.3748/wjg.v20.i24.7707

Full Size Figure Download Figure

Figure 2 Approval dates for chronic hepatitis B therapeutics. IFN: Interferon.

Citation: Wang XY, Chen HS. Emerging antivirals for the treatment of hepatitis B. World J Gastroenterol 2014; 20(24): 7707-7717
URL: https://www.wjgnet.com/1007-9327/full/v20/i24/7707.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i24.7707

Wang XY, Chen HS. Emerging antivirals for the treatment of hepatitis B. World J Gastroenterol 2014; 20(24): 7707-7717 [PMID: 24976708 DOI: 10.3748/wjg.v20.i24.7707]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.